Targeting ‘bubble baby’ disease, this gene therapy company is planting a flag in the East Bay


Orchard Therapeutics is tackling "bubble baby" disease and other rare genetic conditions with gene therapy.

Previous FDA warned drug maker about Hayward manufacturing issues before drug rejection
Next Former Argos Therapeutics CEO finds Belgium company to lead